Dipentum is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Olsalazine Sodium.
Product ID | 68151-0312_75c040b8-d3c3-4df8-adb9-af948f9bc0dd |
NDC | 68151-0312 |
Product Type | Human Prescription Drug |
Proprietary Name | Dipentum |
Generic Name | Olsalazine Sodium |
Dosage Form | Capsule, Gelatin Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-05-15 |
Marketing Category | NDA / NDA |
Application Number | NDA019715 |
Labeler Name | Carilion Materials Management |
Substance Name | OLSALAZINE SODIUM |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2017-12-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019715 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-12-26 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
OLSALAZINE SODIUM | 250 mg/1 |
SPL SET ID: | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0037-6860 | Dipentum | olsalazine sodium |
68151-0312 | Dipentum | olsalazine sodium |
68151-3120 | Dipentum | olsalazine sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DIPENTUM 76481658 not registered Dead/Abandoned |
Celltech Pharmaceuticals, Inc. 2003-01-13 |
DIPENTUM 76481657 not registered Dead/Abandoned |
Celltech Pharmaceuticals, Inc. 2003-01-13 |
DIPENTUM 73506342 1337522 Live/Registered |
Pharmacia, Inc. 1984-10-30 |